TriptoBIO ApS: Financial statements 2025
CVR: 43307495
Source: annual report 2025, Danish Business Authority
01/01/2025 – 31/12/2025
TriptoBIO ApS (CVR 43307495) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK -54,353 and a net result of DKK -4,175,620 compared with DKK -4,449,073 the year before. Equity in the 2025 report amounted to DKK -11,817,513. The company had 5 employees in the financial year.
- Gross Profit
- DKK -54,353
- Profit/Loss
- DKK -4,175,620
- Equity
- DKK -11,817,513
- Total Assets
- DKK 11,751,701
- Employees
- 5
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | - | -54 t. | -4.2 mio. | -11.8 mio. | 5 |
| 2024 | - | -563 t. | -4.4 mio. | -7.6 mio. | 5 |
| 2023 | - | -855 t. | -3.2 mio. | -3.2 mio. | 5 |
How creditworthy is TriptoBIO ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2025
TriptoBIO ApS has published its annual report for 2024. Gross profit came to DKK -562,643, and the net result was DKK -4,449,073.
About TriptoBIO ApS
TriptoBIO ApS is a Danish company of the type Anpartsselskab based in København Ø, founded in 2022. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Jon Rune Christensen and Johan Andersen-Ranberg. The company is owned by JRC Holding HL ApS and JAR ApS. In 2025, the company reported a gross profit of DKK -54,353 and a net result of DKK -4,175,620 compared with DKK -4,449,073 the year before. Equity in the 2025 report amounted to DKK -11,817,513.